Skip to main content
. 2023 Jul 24;7(6):2361–2366. doi: 10.1016/j.jseint.2023.06.024

Table I.

Patient demographics and comorbidities for nondiabetics, noninsulindependent diabetics, and insulin-dependent diabetics.

Normal (nondiabetic)
NIDDM (non-insulin dependent)
IDDM (insulin dependent)
Number (%) Number (%) P value Number (%) P value
Overall 33,302 (100.0) 4758 (100.0) 1817 (100.0)
Sex .702 .092
 Female 13,529 (40.6) 1904 (40.0) 775 (42.7)
 Male 19,762 (59.4) 2854 (60.0) 1042 (57.3)
Age, yr <.001 .986
 >50 7119 (21.4) 444(9.3) 208 (11.5)
 50-59 11,005 (33.0) 1457 (30.6) 574 (31.6)
 60-69 10,666 (32.0) 1886 (39.7) 729 (40.1)
 ≥70 4152 (13.6) 971 (20.4) 305 (16.8)
BMI (kg/mˆ2) <.001 <.001
 <18.5 160 (0.5) 10 (0.2) 2 (0.1)
 18.5-29.9 17,956 (54.0) 1518 (32.0) 489 (26.9)
 30-34.9 8842(26.6) 1548 (32.5) 518 (28.5)
 35-39.9 3385 (10.2) 953 (20.0) 412 (22.7)
 ≥40 2459 (7.4) 729 (15.3) 396 (21.8)
Functional status prior to surgery .570 <.001
 Independent 33,203 (99.7) 4470 (99.6) 1791 (98.6)
 Dependent 99 (0.7) 18 (0.4) 26 (1.4)
ASA classification <.001 <.001
 ≤2 23,921 (71.8) 1737 (36.5) 422 (23.2)
 ≥3 9381 (28.2) 3021 (63.5) 1395 (76.8)
Smoker .002 .457
 No 29,324 (85.0) 4127 (86.7) 1557 (85.7)
 Yes 4978 (15.0) 61 (13.3) 260 (14.3)
Steroid use .626 .626
 No 32,637 (98.0) 4668 (98.1) 1764 (97.1)
 Yes 665 (2.0) 90 (1.9) 53 (2.9)
Comorbidities
Disseminated cancer 18 (0.1) 3 (0.1) .805 1 (0.1) .986
Open wound/infection 20 (0.1) 11 (0.2) <.0001 7 (0.4) <.001
HTN 12,772 (38.4) 3668 (77.1) <.001 1479 (81.4) <.001
COPD 838 (2.5) 172 (3.6) <.001 103 (5.7) <.001
Bleeding disorder 373 (1.1) 104 (2.2) <.001 64 (3.5) <.0001
ARF 1 (0.0) 0 (0.0) 1.000 3 (0.2) <.001
Hospitalization to operation (>1) 98 (0.0) 21 (0.0) .056 11 (0.0) .017

BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; HTN, Hypertension; ARF, acute renal failure.

Bold P values indicate statistical significance with P < .05.